Compounding of drug products; notice. (HB1119)
Introduced By
Progress
✓ |
Introduced |
✗ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Compounding of drug products; notice. Requires pharmacists to notify patients to whom compounded drug products are dispensed that the drug product has been compounded. This bill is carried over pursuant to Rule 22 of the House. Read the Bill »
Outcome
Bill Has Failed
History
| Date | Action |
|---|---|
| 01/13/2014 | Presented and ordered printed 14103021D |
| 01/13/2014 | Referred to Committee on Health, Welfare and Institutions |
| 01/17/2014 | Assigned HWI sub: Subcommittee #2 |
| 01/23/2014 | Subcommittee recommends continuing to 2015 |
| 01/23/2014 | Impact statement from DPB (HB1119) |
| 01/28/2014 | Continued to 2015 in Health, Welfare and Institutions |
| 12/04/2014 | Left in Health, Welfare and Institutions |